Navigation Links
Dendreon Announces Webcast Presentation at BIO CEO & Investor Conference
Date:2/7/2008

SEATTLE, Feb. 7 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN) today announced that Mitchell H. Gold, M.D., chairman and chief executive officer of Dendreon, will present a company update at the 10th Annual BIO CEO & Investor Conference in New York City, on Wednesday, February 13, 2008 at 1:15 p.m. ET.

A live audio webcast of the presentation will be accessible through the Investor Relations section of the Dendreon website, http://www.dendreon.com. If you are unable to listen to the live webcast, it will be archived on the site following the presentation. To access the replay, go to the Investor Relations section of the website.

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response. Active cellular immunotherapy holds promise because it may provide patients with a meaningful clinical benefit, such as survival, combined with low toxicity. The Company has its headquarters in Seattle, Washington and is traded on the Nasdaq Global Market under the symbol DNDN. For more information about the Company and its programs, visit http://www.dendreon.com.


'/>"/>
SOURCE Dendreon Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Dendreon Promotes Dr. Mark Frohlich to Senior Vice President of Clinical Affairs and Chief Medical Officer
2. Dendreon Reports Third Quarter 2007 Financial Results
3. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
4. Dendreon Secures $130 Million Committed Equity Financing Facility
5. Dendreon Announces Webcast Presentation at UBS Life Sciences Conference
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. VIRxSYS Announces Interim Results from VRX496 Gene Therapy Phase II Trial
8. Exelixis Announces February 12 Webcast of Presentation at the 10th Annual BIO CEO and Investor Conference
9. Global Probiotics Council Announces Young Investigator Grant for Probiotics Research to Fund the Next Generation of Gut Microbiota Research
10. Shengtai Pharmaceutical, Inc. Announces Conference Call to Discuss Second Quarter Results of Fiscal Year 2008
11. Meditrina Pharmaceuticals, Inc. Announces Exclusive Global License Agreement With AstraZeneca
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...adigm Corporation, a leading,developer of targete...today,announced the issuance of United States pat... for Controlling Efficacy of RNA Silencing." The ...arch of Philip Zamore, Ph.D., the,Gretchen Stone ... Biochemistry,& Molecular Pharmacology at Un...
(Date:12/2/2008)...-- Cardiogenesis Corporation (Pink Sheets: CGCP), ...he treatment of patients suffering from severe ang...al device executive and an experienced public comp...Company,s Board of Directors, increasing the numbe...9, has over 25 years of executive experience in th...
(Date:12/2/2008)...-- Endocare, Inc.,(Nasdaq: ENDO ), an innovativ...nt of minimally invasive technologies used by urol... and tumor ablation, announced today,that physici...yo Clinic,Memorial Sloan-Kettering Cancer Center...ine , among others, will present a total of 38 sci...
(Date:12/2/2008)...O of market research firm SharpBrains, will lead a...vents of 2008 with leading healthcare and insuranc...sco, CA (PRWEB) December 2, 2008 -- Alvaro Fernand...nomic Forum,s Council on the Challenges of Geronto...ognitive Fitness Events of 2008 on Thursday, Dece...
Breaking Biology Technology:Intradigm Announces Issuance of Key Patent Related to Enhancing Efficacy and Potency of RNAi Therapeutics 2Intradigm Announces Issuance of Key Patent Related to Enhancing Efficacy and Potency of RNAi Therapeutics 3Cardiogenesis Announces Addition of Raymond W. Cohen to Board of Directors 2Cardiogenesis Announces Addition of Raymond W. Cohen to Board of Directors 338 Cryoablation Studies, Exhibits Presented at National Radiological Society Meeting 238 Cryoablation Studies, Exhibits Presented at National Radiological Society Meeting 338 Cryoablation Studies, Exhibits Presented at National Radiological Society Meeting 4Top 10 Cognitive Fitness Events of 2008 to be Unveiled at SharpBrains' Webinar 2Top 10 Cognitive Fitness Events of 2008 to be Unveiled at SharpBrains' Webinar 3
... IT organizations rank high in national survey by ...ing United States businesses to ever-higher effici.... , ,No matter if it is enterprise resource planni...lined manufacturing software, IT is the vice that ...hat makes inclusion on the most recent Information...
...HICAGO Way back in the day, I had a problem. , ,...shed conservatory of music and I needed to finish ...delein College in Chicago that my two years of sig...ood for some transfer credits. , ,I then buckled ...few years of evenings and weekends. , ,Typically,...
...tilizing reliable market research on an ongoing ba...ul marketing campaign. Nevertheless, for many comp...ch and the costs of conducting marketing research ...can be expensive. Not knowing your customers needs...s quagmire is to go on gut instinct or apply someo...
... recently traveled to an event in Madison, Wis. th...echnology Network. It was designed to bring togeth...oncentration: Madison, Milwaukee and of course Chi... event (but the first to go on the road), the idea...n and women come together to meet each other for a...
Other Biology Technology:Wisconsins Business IT Innovators 2Avoid Trading Tech Relationships Like Pokmon Cards 2Avoid Trading Tech Relationships Like Pokmon Cards 3Talking Bout My Generation: The Evolution of Online Marketing Research 2Talking Bout My Generation: The Evolution of Online Marketing Research 3Mike Rosen Reviews - eXtreme Networking in Madison 2Mike Rosen Reviews - eXtreme Networking in Madison 3
(Date:12/2/2008)...gers, The State University of New Jersey, has rece...t Wood Johnson Foundation to establish the Institu.... Cook Campus. , Rutgers President Richard L. McC...w institute during his Annual Address to the Unive...rmick made it clear the new institute would focus ...
(Date:12/2/2008)...le in German . , , Sometimes physicists r...ientists at the Max Planck Institute for Metals Re...do School of Mines have constructed micromachines ...ships into a bottle where the masts and rigging of...he bottle. In the same way, the scientists link th...
(Date:12/2/2008).... 2, 2008 Presbycusis, or age-related hearing los...o, why do some people lose their hearing as they g...p? , The answer may be in a study released onl...ance access is available online at http://hmg.oxf...the first ever and largest genome-wide association...
(Date:12/1/2008)...covering the meaning of a rare mineral that can be...sity geologist Tim Lowenstein is helping climatolo...ably in for over the next century or two as global...ely, to change life as we know it. , "I think t...t hundred years or so, and that many species will ...
Breaking Biology News(10 mins):Rutgers receives US$10 million to establish Institute for Food, Nutrition and Health 2Ship-in-a-bottle kit on a microchip 2Ship-in-a-bottle kit on a microchip 3House Ear Institute, TGen and Belgian researchers identify gene in age-related hearing loss 2Foretelling a major meltdown 2Foretelling a major meltdown 3China Nepstar Chain Drugstore to Implement SAP ERP Solution to Optimize Management and Cost Controls and Enhance Operating Efficiencies 13371 1China Nepstar Chain Drugstore to Implement SAP ERP Solution to Optimize Management and Cost Controls and Enhance Operating Efficiencies 13371 2China Nepstar Chain Drugstore to Implement SAP ERP Solution to Optimize Management and Cost Controls and Enhance Operating Efficiencies 13371 3China Biologic Products Commences Trading on OTC Bulletin Board 3686 1China Biologic Products Commences Trading on OTC Bulletin Board 3686 2NuVasive Prices 24200 Million Convertible Senior Notes Due 2013 13369 1NuVasive Prices 24200 Million Convertible Senior Notes Due 2013 13369 2NuVasive Prices 24200 Million Convertible Senior Notes Due 2013 13369 3Elsevier Launches Publishing Ethics Resource Kit 13368 1Elsevier Launches Publishing Ethics Resource Kit 13368 2
... 5 in an advanced, online edition of the Proceedin... significant enhancement of the treatment of metas...owed the new hybrid compound remained in circulati...rug was cleared in a matter of minutes. , "Althou..., these new findings could have broad application ...
...ng effect on some of the world,s finest coral reef...rt to show the long-term impact of sea temperature... sections of coral reefs and much of the marine li... international team of researchers, who surveyed 2...fs in the inner islands of the Seychelles in 1994 ...
...e University at Buffalo has received a $1.98 milli...estigate the potential of bone marrow-derived adul...n known as hibernating myocardium. , Hibernating m... have experienced reduced blood flow over an exten...es adapt to this deprivation by down-regulating me...
... subject their subordinates to escalating aggressi...verly stressed and as a result infertile, a new st... the latter half of her pregnancy, the dominant fe...inate females from the group for an average of thr...pically those with whom reproductive conflict is m...
Other Biology News:Researchers unveil strategy for creating actively-programmed anti-cancer molecules 2Researchers unveil strategy for creating actively-programmed anti-cancer molecules 3Global warming may have damaged coral reefs forever 2Adult stem cell research at UB targets damaged hearts 2Dominant meerkats render rivals infertile 2
NPT1 (M-19)
XA7 B6
Total Proteins from over 50 different human Alzheimer, Diabetic, Liver Cirrhosis, and Lupus diseased tissues are available.
...Wolf valve has the highest performance characteris...able on the market. This VSO valve offers silent o...ce, and ensures maximum accuracy., Achieves rapi...and patient comfort. , Maintains ideal flow throug...
Biology Products: